256 related articles for article (PubMed ID: 33540821)
21. Pantoprazole blocks the JAK2/STAT3 pathway to alleviate skeletal muscle wasting in cancer cachexia by inhibiting inflammatory response.
Guo D; Wang C; Wang Q; Qiao Z; Tang H
Oncotarget; 2017 Jun; 8(24):39640-39648. PubMed ID: 28489606
[TBL] [Abstract][Full Text] [Related]
22. Chemotherapy-induced loss of bone and muscle mass in a mouse model of breast cancer bone metastases and cachexia.
Hain BA; Xu H; Wilcox JR; Mutua D; Waning DL
JCSM Rapid Commun; 2019; 2(1):. PubMed ID: 31032492
[TBL] [Abstract][Full Text] [Related]
23. Tumor-derived IL-6 and trans-signaling among tumor, fat, and muscle mediate pancreatic cancer cachexia.
Rupert JE; Narasimhan A; Jengelley DHA; Jiang Y; Liu J; Au E; Silverman LM; Sandusky G; Bonetto A; Cao S; Lu X; O'Connell TM; Liu Y; Koniaris LG; Zimmers TA
J Exp Med; 2021 Jun; 218(6):. PubMed ID: 33851955
[TBL] [Abstract][Full Text] [Related]
24. Imperatorin alleviates cancer cachexia and prevents muscle wasting via directly inhibiting STAT3.
Chen L; Xu W; Yang Q; Zhang H; Wan L; Xin B; Zhang J; Guo C
Pharmacol Res; 2020 Aug; 158():104871. PubMed ID: 32413482
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of heat shock protein (HSP) 90 reverses signal transducer and activator of transcription (STAT) 3-mediated muscle wasting in cancer cachexia mice.
Niu M; Song S; Su Z; Wei L; Li L; Pu W; Zhao C; Ding Y; Wang J; Cao W; Gao Q; Wang H
Br J Pharmacol; 2021 Nov; 178(22):4485-4500. PubMed ID: 34265073
[TBL] [Abstract][Full Text] [Related]
26. Cucurbitacin IIb attenuates cancer cachexia induced skeletal muscle atrophy by regulating the IL-6/STAT3/FoxO signaling pathway.
Wang Y; Sun X; Yang Q; Guo C
Phytother Res; 2023 Aug; 37(8):3380-3393. PubMed ID: 37073890
[TBL] [Abstract][Full Text] [Related]
27. Evidence for the contribution of insulin resistance to the development of cachexia in tumor-bearing mice.
Asp ML; Tian M; Wendel AA; Belury MA
Int J Cancer; 2010 Feb; 126(3):756-63. PubMed ID: 19634137
[TBL] [Abstract][Full Text] [Related]
28. FoxP1 is a transcriptional repressor associated with cancer cachexia that induces skeletal muscle wasting and weakness.
Neyroud D; Nosacka RL; Callaway CS; Trevino JG; Hu H; Judge SM; Judge AR
J Cachexia Sarcopenia Muscle; 2021 Apr; 12(2):421-442. PubMed ID: 33527776
[TBL] [Abstract][Full Text] [Related]
29. Selumetinib Attenuates Skeletal Muscle Wasting in Murine Cachexia Model through ERK Inhibition and AKT Activation.
Quan-Jun Y; Yan H; Yong-Long H; Li-Li W; Jie L; Jin-Lu H; Jin L; Peng-Guo C; Run G; Cheng G
Mol Cancer Ther; 2017 Feb; 16(2):334-343. PubMed ID: 27599525
[TBL] [Abstract][Full Text] [Related]
30. Amiloride ameliorates muscle wasting in cancer cachexia through inhibiting tumor-derived exosome release.
Zhou L; Zhang T; Shao W; Lu R; Wang L; Liu H; Jiang B; Li S; Zhuo H; Wang S; Li Q; Huang C; Lin D
Skelet Muscle; 2021 Jul; 11(1):17. PubMed ID: 34229732
[TBL] [Abstract][Full Text] [Related]
31. Repetitive TLR3 activation in the lung induces skeletal muscle adaptations and cachexia.
Graber TG; Rawls BL; Tian B; Durham WJ; Brightwell CR; Brasier AR; Rasmussen BB; Fry CS
Exp Gerontol; 2018 Jun; 106():88-100. PubMed ID: 29452288
[TBL] [Abstract][Full Text] [Related]
32. The Role of Tumor Microenvironment Cells in Colorectal Cancer (CRC) Cachexia.
Kasprzak A
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33557173
[TBL] [Abstract][Full Text] [Related]
33. A Key Role for Leukemia Inhibitory Factor in C26 Cancer Cachexia.
Seto DN; Kandarian SC; Jackman RW
J Biol Chem; 2015 Aug; 290(32):19976-86. PubMed ID: 26092726
[TBL] [Abstract][Full Text] [Related]
34. Voluntary exercise does not improve muscular properties or functional capacity during C26-induced cancer cachexia in mice.
Hiroux C; Dalle S; Koppo K; Hespel P
J Muscle Res Cell Motil; 2021 Jun; 42(2):169-181. PubMed ID: 33606189
[TBL] [Abstract][Full Text] [Related]
35. Blockade of the IL-6 trans-signalling/STAT3 axis suppresses cachexia in Kras-induced lung adenocarcinoma.
Miller A; McLeod L; Alhayyani S; Szczepny A; Watkins DN; Chen W; Enriori P; Ferlin W; Ruwanpura S; Jenkins BJ
Oncogene; 2017 May; 36(21):3059-3066. PubMed ID: 27893707
[TBL] [Abstract][Full Text] [Related]
36. Effect of tumor burden and subsequent surgical resection on skeletal muscle mass and protein turnover in colorectal cancer patients.
Williams JP; Phillips BE; Smith K; Atherton PJ; Rankin D; Selby AL; Liptrot S; Lund J; Larvin M; Rennie MJ
Am J Clin Nutr; 2012 Nov; 96(5):1064-70. PubMed ID: 23034966
[TBL] [Abstract][Full Text] [Related]
37. The protective effect of cannabinoids against colorectal cancer cachexia through modulation of inflammation and immune responses.
Ng SK; Chung DJ; Chang LC; Luo CK; Jwo SH; Lee YH; Lin JS; Wang CH; Wei TT
Biomed Pharmacother; 2023 May; 161():114467. PubMed ID: 36871538
[TBL] [Abstract][Full Text] [Related]
38. Altered expression of skeletal muscle myosin isoforms in cancer cachexia.
Diffee GM; Kalfas K; Al-Majid S; McCarthy DO
Am J Physiol Cell Physiol; 2002 Nov; 283(5):C1376-82. PubMed ID: 12372798
[TBL] [Abstract][Full Text] [Related]
39. Nuclear magnetic resonance in conjunction with functional genomics suggests mitochondrial dysfunction in a murine model of cancer cachexia.
Constantinou C; Fontes de Oliveira CC; Mintzopoulos D; Busquets S; He J; Kesarwani M; Mindrinos M; Rahme LG; Argilés JM; Tzika AA
Int J Mol Med; 2011 Jan; 27(1):15-24. PubMed ID: 21069263
[TBL] [Abstract][Full Text] [Related]
40. Luteolin reduces cancer‑induced skeletal and cardiac muscle atrophy in a Lewis lung cancer mouse model.
Chen T; Li B; Xu Y; Meng S; Wang Y; Jiang Y
Oncol Rep; 2018 Aug; 40(2):1129-1137. PubMed ID: 29845270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
